124 related articles for article (PubMed ID: 33123789)
1. Predictive factors of severe abdominal pain during and after transarterial chemoembolization for hepatocellular carcinoma.
Pachev A; Raynaud L; Paulatto L; Dioguardi Burgio M; Roche V; Garcia Alba C; Sibert A; Lagadec M; Kavafyan-Lasserre J; Paugam-Burtz C; Vilgrain V; Ronot M
Eur Radiol; 2021 May; 31(5):3267-3275. PubMed ID: 33123789
[TBL] [Abstract][Full Text] [Related]
2. Predictive model for acute abdominal pain after transarterial chemoembolization for liver cancer.
Bian LF; Zhao XH; Gao BL; Zhang S; Ge GM; Zhan DD; Ye TT; Zheng Y
World J Gastroenterol; 2020 Aug; 26(30):4442-4452. PubMed ID: 32874056
[TBL] [Abstract][Full Text] [Related]
3. Construction and Validation of Prediction Model of Severe Abdominal Pain Post-Transarterial Chemoembolization in Patients with HBV-Associated Primary Liver Cancer.
Yang Y; Chen S; Yan Z; Jiao Y; Yan X; Li Y
Comput Math Methods Med; 2022; 2022():5203166. PubMed ID: 35941895
[TBL] [Abstract][Full Text] [Related]
4. Risks factors for severe pain after selective liver transarterial chemoembolization.
Benzakoun J; Ronot M; Lagadec M; Allaham W; Garcia Alba C; Sibert A; Vilgrain V
Liver Int; 2017 Apr; 37(4):583-591. PubMed ID: 27529160
[TBL] [Abstract][Full Text] [Related]
5. Improving pain control during transarterial chemoembolization for hepatocellular carcinoma performed under local anesthesia with multimodal analgesia.
Vanderbecq Q; Grégory J; Dana J; Dioguardi Burgio M; Garzelli L; Raynaud L; Frémy S; Paulatto L; Bouattour M; Kavafyan-Lasserre J; Vilgrain V; Ronot M
Diagn Interv Imaging; 2023 Mar; 104(3):123-132. PubMed ID: 36805801
[TBL] [Abstract][Full Text] [Related]
6. Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration.
Lee SH; Hahn ST; Park SH
Cardiovasc Intervent Radiol; 2001; 24(6):368-71. PubMed ID: 11907741
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors of transarterial chemoembolisation toxicity in unresectable hepatocellular carcinoma.
Boulin M; Adam H; Guiu B; Aho LS; Cercueil JP; Di Martino C; Fagnoni P; Minello A; Jouve JL; Hillon P; Bedenne L; Lepage C
Dig Liver Dis; 2014 Apr; 46(4):358-62. PubMed ID: 24462550
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Liver Function Deterioration after Transarterial Chemoembolization Refractoriness in Child-Pugh Class A Hepatocellular Carcinoma Patients.
Park KH; Kim JH; Choe WH; Kwon SY; Yoo BC; Hwang JH; Park SW; Kim YJ; Park HS; Yu MH; Jeon HJ
Korean J Gastroenterol; 2020 Mar; 75(3):147-156. PubMed ID: 32209803
[TBL] [Abstract][Full Text] [Related]
9. Nomogram for predicting severe abdominal pain after initial conventional transarterial chemoembolisation for hepatocellular carcinoma: a retrospective study.
Qin H; Xiao X; Ya H; Li J; Liang F; Jin H; Liao L; Li Y; Qin J; Yu J; Gu J; Zhou C; Jin M; Miao Y; Li S
Sci Rep; 2023 Dec; 13(1):22397. PubMed ID: 38104191
[TBL] [Abstract][Full Text] [Related]
10. Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis.
Roehlen N; Stoehr F; Müller L; Luxenburger H; Gairing SJ; Reincke M; Schultheiss M; Berisha F; Weinmann A; Foerster F; Marquardt JU; Thimme R; Galle PR; Bettinger D; Kloeckner R
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37756031
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting post-embolization fever and liver failure after trans-arterial chemo-embolization in a cohort without background infective hepatitis- a prospective analysis.
Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage CA; Upasena A; Sirigampala C; de Silva HJ
BMC Gastroenterol; 2015 Aug; 15():96. PubMed ID: 26239844
[TBL] [Abstract][Full Text] [Related]
12. Postintervention Interleukin-6 (IL-6) Level, Rather than the Pretreatment or Dynamic Changes of IL-6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Wu Y; Fan W; Xue M; Zhong B; Zhang S; Wang Y; Yao W; Zhao Y; Li J
Oncologist; 2019 Dec; 24(12):e1489-e1495. PubMed ID: 31249138
[TBL] [Abstract][Full Text] [Related]
13. Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study.
Wang ZX; Wang EX; Bai W; Xia DD; Mu W; Li J; Yang QY; Huang M; Xu GH; Sun JH; Li HL; Zhao H; Wu JB; Yang SF; Li JP; Li ZX; Zhang CQ; Zhu XL; Zheng YB; Wang QH; Li J; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH; On Behalf Of China Hcc-Tace Study Group
World J Gastroenterol; 2020 Feb; 26(6):657-669. PubMed ID: 32103874
[TBL] [Abstract][Full Text] [Related]
14. A Predictive Model for Postembolization Syndrome after Transarterial Hepatic Chemoembolization of Hepatocellular Carcinoma.
Khalaf MH; Sundaram V; AbdelRazek Mohammed MA; Shah R; Khosla A; Jackson K; Desai M; Kothary N
Radiology; 2019 Jan; 290(1):254-261. PubMed ID: 30299233
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study.
Huo TI; Wu JC; Lee PC; Chang FY; Lee SD
Liver Int; 2004 Jun; 24(3):210-5. PubMed ID: 15189271
[TBL] [Abstract][Full Text] [Related]
16. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Opioid Medication Use after Conventional Chemoembolization versus Drug-Eluting Embolic Chemoembolization.
Khalaf MH; Shah RP; Green V; Vezeridis AM; Liang T; Kothary N
J Vasc Interv Radiol; 2020 Aug; 31(8):1292-1299. PubMed ID: 32654960
[TBL] [Abstract][Full Text] [Related]
18. Incidence, risk factors, and prognosis of acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma: a prospective cohort study.
Hao JF; Zhang LW; Bai JX; Li YJ; Liu JN; Zhang XL; Han JM; Li X; Jiang H; Cao N
Indian J Cancer; 2015 Feb; 51 Suppl 2():e3-8. PubMed ID: 25712839
[TBL] [Abstract][Full Text] [Related]
19. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
Zhang DZ; Wei XD; Wang XP
World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
[TBL] [Abstract][Full Text] [Related]
20. Abdominal Pain After Transarterial Chemoembolization.
Salim Z; Laycock A; Hewavitharana C
Gastroenterology; 2023 Jan; 164(1):27-29. PubMed ID: 35870515
[No Abstract] [Full Text] [Related]
[Next] [New Search]
